Efficacy of radical prostatectomy for stage A2 XXXX .

@entity1 @entity263 @entity66 @entity322 @entity5 @entity189 @entity3
Optimal management of @entity1 with diffuse incidental @entity263 (Stage A2) is an unresolved issue. Current forms of therapy include radical prostatectomy, external beam radiation therapy, and no treatment. Long-term results with curative therapy have been unreported because of the relatively recent substaging of Stage A into incidental and @entity66 . The results of radical prostatectomy in 25 @entity1 with Stage A2 @entity263 were reviewed. @entity322 was the most serious complication and occurred in four @entity1 (16%). Pathologically, 24 @entity1 (96%) had @entity189 present in the radical prostatectomy specimen. In 22 @entity1 (88%) the @entity5 was entirely confined to the prostate. Two @entity1 (8%) demonstrated @entity3 , and one (4%) had capsular penetration. In follow-up metastatic disease has developed in one @entity1 , and another died without evidence of @entity5 . The remaining @entity1 are alive without evidence of disease. Since 88% of @entity1 with Stage A2 disease have their @entity5 entirely confined to the prostate, radical prostatectomy offers an excellent chance of long-term cure, as in Stage B @entity263 .
